EP1216066A1 - Compositions for the treatment of wound contracture - Google Patents

Compositions for the treatment of wound contracture

Info

Publication number
EP1216066A1
EP1216066A1 EP00964446A EP00964446A EP1216066A1 EP 1216066 A1 EP1216066 A1 EP 1216066A1 EP 00964446 A EP00964446 A EP 00964446A EP 00964446 A EP00964446 A EP 00964446A EP 1216066 A1 EP1216066 A1 EP 1216066A1
Authority
EP
European Patent Office
Prior art keywords
wound
contracture
orc
oxidized cellulose
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00964446A
Other languages
German (de)
English (en)
French (fr)
Inventor
Breda Mary Cullen
Derek Walter Silcock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Medical Ltd
Original Assignee
Johnson and Johnson Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Medical Ltd filed Critical Johnson and Johnson Medical Ltd
Publication of EP1216066A1 publication Critical patent/EP1216066A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
EP00964446A 1999-10-01 2000-09-29 Compositions for the treatment of wound contracture Withdrawn EP1216066A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9923291 1999-10-01
GB9923291A GB2354708B (en) 1999-10-01 1999-10-01 Compositions for the treatment of wound contracture
PCT/GB2000/003744 WO2001024841A1 (en) 1999-10-01 2000-09-29 Compositions for the treatment of wound contracture

Publications (1)

Publication Number Publication Date
EP1216066A1 true EP1216066A1 (en) 2002-06-26

Family

ID=10861983

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00964446A Withdrawn EP1216066A1 (en) 1999-10-01 2000-09-29 Compositions for the treatment of wound contracture

Country Status (5)

Country Link
EP (1) EP1216066A1 (ja)
JP (1) JP2003511099A (ja)
AU (1) AU7538100A (ja)
GB (1) GB2354708B (ja)
WO (1) WO2001024841A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2373724B (en) * 2001-03-28 2005-02-02 Johnson & Johnson Medical Ltd Peptides for the treatment of wound contracture
CA2495541C (en) 2002-09-11 2011-07-12 Johnson & Johnson Medical Limited Wound dressing materials comprising complexes of anionic polysaccharides with silver
GB2392913B (en) * 2002-09-11 2007-04-04 Johnson & Johnson Medical Ltd Wound dressings comprising complexes of oxidised celluloses with silver
EP1601388B1 (en) * 2003-03-10 2011-04-27 Johnson & Johnson Medical Ltd. Hydrocolloid materials for use in wound healing
GB2399289B (en) * 2003-03-10 2006-03-08 Johnson & Johnson Medical Ltd Hydrocolloid materials for use in wound healing
EP2720667A2 (en) * 2011-06-16 2014-04-23 Unilever PLC Aqueous gels
US8815832B2 (en) 2012-05-25 2014-08-26 Ethicon, Inc. Oxidized regenerated cellulose hemostatic powders and methods of making
CN104368049B (zh) * 2014-11-12 2017-02-15 无锡中科光远生物材料有限公司 氧化纤维素体系的止血防粘连的复合材料及其制备方法
CN107530212B (zh) * 2015-04-24 2021-10-26 郡是株式会社 生物组织加固材料
CN105401242A (zh) * 2015-10-23 2016-03-16 徐爱军 具有抗菌消炎功效的医用无纺布及制备方法
CN108348633B (zh) 2015-11-06 2022-07-08 伊西康公司 压实止血纤维素聚集体
US10137220B2 (en) 2015-11-08 2018-11-27 Omrix Biopharmaceuticals Ltd. Hemostatic composition
CN107754005B (zh) 2016-08-15 2021-06-15 广州倍绣生物技术有限公司 止血组合物及其制造方法
US11413335B2 (en) 2018-02-13 2022-08-16 Guangzhou Bioseal Biotech Co. Ltd Hemostatic compositions and methods of making thereof
JP6868129B2 (ja) * 2017-10-13 2021-05-12 グンゼ株式会社 生体組織補強材料キット及び生体組織補強材料

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0337739A2 (en) * 1988-04-12 1989-10-18 Glaxo Group Limited Use of TP-receptor antagonists to modify the action of myofibroblasts
EP1325754A1 (en) * 1996-06-28 2003-07-09 Johnson & Johnson Medical Ltd. Wound dressing materials comprising collagen and oxidized cellulose

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
US5414079A (en) * 1993-08-03 1995-05-09 Biocontrol Incorporated Oxidized cellulose
EP0637450A3 (en) * 1993-08-04 1995-04-05 Collagen Corp Method and composition for resuscitation of hereditary tissue.
US5601579A (en) * 1994-12-29 1997-02-11 Medex, Inc. Method for the treatment of bowel adhesions
US5696101A (en) * 1996-04-16 1997-12-09 Eastman Chemical Company Oxidized cellulose and vitamin E blend for topical hemostatic applications
GB2314840B (en) * 1996-06-28 2000-09-06 Johnson & Johnson Medical Oxidized oligosaccharides and pharmaceutical compositions
US6500777B1 (en) * 1996-06-28 2002-12-31 Ethicon, Inc. Bioresorbable oxidized cellulose composite material for prevention of postsurgical adhesions
US5795286A (en) * 1996-08-15 1998-08-18 Cathco, Inc. Radioisotope impregnated sheet of biocompatible material for preventing scar tissue formation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0337739A2 (en) * 1988-04-12 1989-10-18 Glaxo Group Limited Use of TP-receptor antagonists to modify the action of myofibroblasts
EP1325754A1 (en) * 1996-06-28 2003-07-09 Johnson & Johnson Medical Ltd. Wound dressing materials comprising collagen and oxidized cellulose

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KELMAN I. ET AL: "Wound contraction and scar contracture", WOUND HEALING:BIOCHEMICAL & CLINICAL ASPECTS, pages 96 - 114 *
See also references of WO0124841A1 *

Also Published As

Publication number Publication date
JP2003511099A (ja) 2003-03-25
GB9923291D0 (en) 1999-12-08
GB2354708B (en) 2004-06-02
AU7538100A (en) 2001-05-10
WO2001024841A1 (en) 2001-04-12
GB2354708A (en) 2001-04-04

Similar Documents

Publication Publication Date Title
EP1539258B1 (en) Wound dressing compositions comprising chitosan and an oxidised cellulose
JP5160081B2 (ja) 酸化セルロースおよびヒト組換えコラーゲンを含有している創傷包帯
Thomas Alginate dressings in surgery and wound management: Part 2
AU737809B2 (en) Use of oxidized cellulose and complexes thereof for chronic wound healing
US6187743B1 (en) Composition and method for enhancing wound healing
EP1216066A1 (en) Compositions for the treatment of wound contracture
EP0431479A1 (en) Wound surface-covering sheets
EP0914168A1 (en) New medicaments containing gelatin cross-linked with oxidized polysaccharides
CZ230592A3 (en) Methylpyrrolidinone chitosans, process of their preparation and their use
KR20230126734A (ko) 의료 기기, 하이드로겔 및 그의 제조 방법과 응용
CN115869459A (zh) 促伤口愈合的多肽水凝胶及其制备方法与应用
CN114028604A (zh) 一种基于聚合氨基酸的多组分创面修复止血敷料及其应用
EP1372693B1 (en) Peptides for the treatment of wound contracture
CN111760067A (zh) 一种含艾考糊精的组合物及其应用
RU2793743C1 (ru) Способ лечения ран кожи и мягких тканей с помощью раневого покрытия на основе бактериальной целлюлозы
CN111378125B (zh) Pebp嵌段聚合物凝胶及其制备和应用

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020328

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: JOHNSON & JOHNSON MEDICAL LIMITED.

RBV Designated contracting states (corrected)

Designated state(s): DE FR GB IT

17Q First examination report despatched

Effective date: 20041014

RIC1 Information provided on ipc code assigned before grant

Ipc: A61L 26/00 20060101ALI20070912BHEP

Ipc: A61K 47/38 20060101ALI20070912BHEP

Ipc: A61L 15/28 20060101AFI20070912BHEP

Ipc: A61K 31/717 20060101ALN20070912BHEP

Ipc: A61L 15/22 20060101ALI20070912BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080326